BridgeBio Pharma Inc (NASDAQ:BBIO)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BBIO

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BBIO

  • Market Cap$8.556bn
  • SymbolNASDAQ:BBIO
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS10806X1028

Company Profile

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Latest BBIO news

Currently there for this company. Visit our news hub for other news .